Superstar ASX 200 healthcare stock snags record high amid $32 million deal

The second multi-million-dollar deal in less than two weeks.

| More on:
Three Archer Materials scientists wearing white coats and blue gloves dance together in their lab after making a discovery

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On a weak day for the Australian share market, one ASX 200 healthcare stock is relishing in record-achieving status.

Shares in the high-flying Pro Medicus Limited (ASX: PME) hit a fresh all-time high of $191.75 earlier this morning. The excitement has since partially worn off, with shares in the imaging software company slipping 0.1% to $190.18.

Deal details

Pro Medicus had gone four months and nine days without a major contract signing or renewal — longer than usual compared to the last couple of years. Ironically, now the medical imaging software company has landed two deals less than two weeks apart after today's announcement.

According to the release, a 'large Australian radiology network' has signed a five-year contract extension. Yes, the details of which the Australian radiology operator appears to be hush-hush. Pro Medicus' lips are tightly sealed on this one.

The extension will deliver at least $32 million over five years to use the company's Visage RIS product. Positively, the deal was negotiated with an increased fee rate for Pro Medicus. A higher rate was also a feature of last week's $98 million, eight-year renewal with Mercy Health.

Commenting on the deal, Pro Medicus CEO Dr Sam Hupert said:

This contract extension cements our leadership position when it comes to RIS in the Australian market.

Pro Medicus signed a five-year contract with I-MED Radiology — Australia's leading radiology network — in 2018. However, whether today's extension is with I-MED has not been confirmed.

Annual value of contracts signed in each calendar year. Data manually collated from ASX announcements.

Despite the two recent contract extensions, Pro Medicus is currently looking at a decline in annual deal value, as shown above. There are still another two and a half months left in the year — but as it stands, the company has secured $175 million worth of contracts in 2024 versus $257 million last year.

Is this ASX 200 healthcare stock too high?

The last 12 months have been phenomenal for the Pro Medicus share price.

Setting record high after record high, the software company has climbed 131% to reach $190 per share and a corresponding $19.95 billion market capitalisation.

Given that the company's net profits increased by a much smaller 36.5% in FY24, much of the enlarged valuation comes from an expansion in the company's earnings multiple. That is to say, a large portion of the gain can be attributed to investors' willingness to pay a greater premium for this ASX 200 healthcare stock.

A year ago, the price-to-earnings (P/E) ratio on Pro Medicus shares was roughly 132 times earnings. Today — make sure you're sitting down first — the company trades at 240 times earnings.

Nonetheless, three analysts recommend its shares as a buy or strong buy. In contrast, only two analysts recommend Pro Medicus as a sell or strong sell.

Motley Fool contributor Mitchell Lawler has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Record Highs

Four young friends on a road trip smile and laugh as they sit on roof of their car.
ETFs

4 popular ASX tech ETFs smashing new all-time highs today

Do you own any of these lucky ETFs?

Read more »

Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
Record Highs

The multi-billion-dollar ASX tech share hitting new highs on broker bullishness

This ASX tech share darling is up 216% in the year to date and just reset its record price.

Read more »

A cloud with a blue arrow pointing upwards through its middle symbolising a rising asx share price
Record Highs

Xero and 2 other ASX tech shares cracking all-time highs on Thursday

The price peaks follow a significant lift in the NASDAQ overnight following Republican Donald Trump's US election victory.

Read more »

a man wearing a gold shirt smiles widely as he is engulfed in a shower of gold confetti falling from the sky. representing a new gold discovery by ASX mining share OzAurum Resources
ETFs

7 hugely popular ASX ETFs smashing new record highs on Wednesday

Do you own any of these lucky ASX ETFs?

Read more »

Man smiling at a laptop because of a rising share price.
Record Highs

This ASX 200 share is breaking records amid a massive $300 million investment

This ASX 200 share made a triumphant return to trading today.

Read more »

A woman on holiday stands with her arms outstretched joyously in an aeroplane cabin.
Travel Shares

Big ASX news: Qantas share price hits record high

Qantas is defying the market to fly to new heights this Wednesday...

Read more »

ETF written in gold with dollar signs on coin.
ETFs

5 popular ASX ETFs smashing new record highs today

Do you own any of these high-flying funds?

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Record Highs

Boom! The ASX 200 just rocketed to new all-time highs

ASX 200 investors just sent the benchmark into uncharted territory.

Read more »